biostudies-literaturePedersen MSKøbmand I Odense Johan og Hanne Weimann Født Seedorffs LegatKræftens Bekæmpelse (DCS)Kræftens BekæmpelseNovo Nordisk Fonden (NNF)Danske RegionerNovo Nordisk FondenKøbmand I Odense Johan og Hanne Weimann Født Seedorffs Legat (Købmand i Odense Johann og Hanne Weimann født Seedorffs Legat)e0075521https://www.ebi.ac.uk/biostudies/studies/S-EPMC8515882biostudies-literatureUnknown10(41)Limited information is available in relation to surveillance, genotyping, genome sequences, and treatment outcomes for rare hepatitis C virus variants. Here, we have characterized a novel subtype of major hepatitis C virus genotype 1, which was deep sequenced before and after treatment failure with 4 weeks of glecaprevir and pibrentasvir.Microbiology resource announcementsCharacterization of a Novel Hepatitis C Virus Genotype 1 Subtype from a Patient Failing 4 Weeks of Glecaprevir-Pibrentasvir Treatment.PMC8515882NNF18OC0055462NNF18OC0054518Fahnoe UOvrehus ABukh JMadsen LWChristensen PBPedersen MSfalseCharacterization of a Novel Hepatitis C Virus Genotype 1 Subtype from a Patient Failing 4 Weeks of Glecaprevir-Pibrentasvir Treatment.Limited information is available in relation to surveillance, genotyping, genome sequences, and treatment outcomes for rare hepatitis C virus variants. Here, we have characterized a novel subtype of major hepatitis C virus genotype 1, which was deep sequenced before and after treatment failure with 4 weeks of glecaprevir and pibrentasvir.2021-01-01T00:00:00Z2021 Oct2025-04-04T12:22:21.47Z2025-02-19T01:26:04.931ZS-EPMC85158823464779610.1128/MRA.00755-21